Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics
Mayumi Nagashimada, Masao Honda
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8008-8008
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid
Wenchao Wei, Chi Chun Wong, Zhongjun Jia, et al.
Nature Microbiology (2023) Vol. 8, Iss. 8, pp. 1534-1548
Open Access | Times Cited: 98
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 22
Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, et al.
Livers (2022) Vol. 2, Iss. 1, pp. 30-76
Open Access | Times Cited: 44
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
Keungmo Yang, Myeong Jun Song
Nutrients (2023) Vol. 15, Iss. 18, pp. 3970-3970
Open Access | Times Cited: 22
NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Geladari, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 826-826
Open Access | Times Cited: 12
Probiotics and Non-Alcoholic Fatty Liver Disease: Unveiling the Mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in Modulating Lipid Metabolism, Inflammation, and Intestinal Barrier Integrity
Jing Lu, Dilireba Shataer, Huizhen Yan, et al.
Foods (2024) Vol. 13, Iss. 18, pp. 2992-2992
Open Access | Times Cited: 8
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 550-550
Open Access | Times Cited: 34
Stigmasterol Protects Against Steatohepatitis Induced by High-Fat and High-Cholesterol Diet in Mice by Enhancing the Alternative Bile Acid Synthesis Pathway
Yan Xin, Xiang Li, Xuan Zhu, et al.
Journal of Nutrition (2023) Vol. 153, Iss. 7, pp. 1903-1914
Open Access | Times Cited: 16
Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis
Naqash Alam, Linying Jia, Ao Cheng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiota
Jing‐Yuan Xu, Hongyang Tian, Yajun Ji, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 10, pp. 2687-2699
Closed Access | Times Cited: 12
Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease
Li-ting Jin, Mingzhi Xu
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Unravelling the gut-liver axis: The role of gut microbiota-mitochondria interactions in the pathogenesis and management of metabolic-associated fatty liver disease (MAFLD)
Binzhi Zhang, Xia Luo, Lei Song, et al.
Journal of Holistic Integrative Pharmacy (2025) Vol. 6, Iss. 1, pp. 23-40
Open Access
The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis
Seema Sharma, Nidhi Tiwari, Sampat Singh Tanwar
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Live and heat-killed Lacticaseibacillus paracasei 6235 alleviates the inflammatory response of LPS-induced RAW264.7 cells by inhibiting the JAK-STAT signaling pathway
Yucong Wang, Zhixin Xie, Rongxu Liu, et al.
Food Bioscience (2025), pp. 106646-106646
Closed Access
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma
Simona Cernea, Danusia Onișor
World Journal of Gastroenterology (2023) Vol. 29, Iss. 2, pp. 286-309
Open Access | Times Cited: 9
Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy
Yingxin Tian, Yiming Ni, Ting Zhang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
The Activity of Prebiotics and Probiotics in Hepatogastrointestinal Disorders and Diseases Associated with Metabolic Syndrome
Alicia Rodríguez-Pastén, Nury Pérez‐Hernández, Javier Añorve‐Morga, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7229-7229
Open Access | Times Cited: 14
Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease
Anıl Delik, Sadık Dinçer, Yakup Ülger, et al.
Gene (2022) Vol. 833, pp. 146587-146587
Closed Access | Times Cited: 11
Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2/HO-1 and gut microbiota
Ahmed M. El-Baz, Amira M. El-Ganiny, Doaa Hellal, et al.
AMB Express (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease
Chen Yao, Yumeng Gan, Huijie Zhong, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 6
Probiotics and liver fibrosis: An evidence-based review of the latest research
Lin Cheng, Jianyou Shi, Haoyuan Peng, et al.
Journal of Functional Foods (2023) Vol. 109, pp. 105773-105773
Open Access | Times Cited: 4
Physiopathology of nonalcoholic fatty liver disease: from diet to nutrigenomics
Paola Meneghel, Elisa Pinto, Francesco Paolo Russo
Current Opinion in Clinical Nutrition & Metabolic Care (2022) Vol. 25, Iss. 5, pp. 329-333
Open Access | Times Cited: 7
Probiotics—A Promising Novel Therapeutic Approach in the Management of Chronic Liver Diseases
Gokulapriya Ramachandran, Biju Pottakkat
Journal of Medicinal Food (2024) Vol. 27, Iss. 6, pp. 467-476
Closed Access
Dysfunction of the Murine Liver with Aging and Its Improvement with the Continuous Consumption of Enterococcus faecalis EC-12
Yuko Makioka‐Itaya, Ryo Inoüe, Takamitsu Tsukahara
Nutrients (2024) Vol. 16, Iss. 13, pp. 2031-2031
Open Access
Gut microbiome and liver diseases
Jun Xu, Ning Chen, Li Zhou, et al.
Fundamental Research (2024)
Open Access
Page 1 - Next Page

Scroll to top